Rescheduled Investor Call

Quarterly Activity Report and Appendix 4C-June 2023

Change of Director’s Interest Notice – John Barrington

Notification of cessation of securities – AYA

Secondary Trading Notice

Company Presentation – MST Digital Health Forum

AYA Conducts Successful Q-Submission Meeting with FDA

Application for quotation of securities – AYA

Change of Director’s Interest Notice – K Hill

Artrya Lodges Key Submission in FDA Process